DCN and neoplasm: Furthermore, it is known that decorin antagonizes the angiogenic network [106] due to the inhibition of the production of VEGF (vascular endothelial growth factor) by tumor cells and can directly blocking of VEGFR2 (vascular endothelial growth factor receptor-2) at the same time [107].